in situ Hi-C4DNEXTFBCC3I
released
October 17th, 2024 at 9:15pm
Properties
Experiment Type
Follows SOP
No
Biosample
Digestion Enzyme
Biosample Modifications
None
Biosample Treatments
Thymidine treatment (2.0 mM, 14.0h) and Nocodazole treatment (20.0 ng/mL, 2.0h) and dTAGv-1 treatment (500.0 nM, 2.0h)